Moreover, this accelerated utilization of the drug is further fueled by healthcare providers striving to improve treatment results, consequently bolstering the significant development of the GLP-1 receptor agonist market
We do not offer medical advice, we do not dispense medicines, and we do not promote any product for the diagnosis, treatment, cure, or prevention of any disease or condition in humans or animals
When you start a new treatment, your body needs time to adjust
It may also be an option for individuals with a BMI of 27 or higher, particularly if they have weight-related health issues like high blood pressure or diabetes
GLP-1 side effects are usually mild and temporary
It has also received approval for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity